We are live on ! Find out more
PRC

Platte River Capital Portfolio holdings

AUM $108M
1-Year Est. Return 0.26%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
-0.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$859M
AUM Growth
Cap. Flow
+$860M
Cap. Flow %
100.06%
Top 10 Hldgs %
21.03%
Holding
198
New
198
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$30.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$26M
3
GE icon
GE Aerospace
GE
+$17.8M
4
MSFT icon
Microsoft
MSFT
+$16.1M
5
PFE icon
Pfizer
PFE
+$15.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.44%
2 Technology 18.12%
3 Energy 11.03%
4 Financials 10.85%
5 Consumer Staples 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.8T
$28M 3.26%
+1,978,340
New +$30.4M
JNJ icon
2
Johnson & Johnson
JNJ
$599B
$26.3M 3.06%
+306,359
New +$26M
GE icon
3
GE Aerospace
GE
$354B
$17.9M 2.08%
+160,854
New +$17.8M
MSFT icon
4
Microsoft
MSFT
$2.99T
$17M 1.98%
+491,694
New +$16.1M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.29T
$16.4M 1.91%
+749,238
New +$15.8M
CSCO icon
6
Cisco
CSCO
$436B
$15.5M 1.81%
+638,104
New +$14.4M
PEP icon
7
PepsiCo
PEP
$185B
$15.5M 1.8%
+188,930
New +$15.4M
PFE icon
8
Pfizer
PFE
$141B
$15.3M 1.78%
+573,892
New +$15.9M
PG icon
9
Procter & Gamble
PG
$347B
$14.7M 1.72%
+191,405
New +$15M
KO icon
10
Coca-Cola
KO
$353B
$14.1M 1.64%
+350,322
New +$14.5M
GILD icon
11
Gilead Sciences
GILD
$165B
$13.9M 1.62%
+271,830
New +$14.2M
BMY icon
12
Bristol-Myers Squibb
BMY
$123B
$13M 1.51%
+291,085
New +$12.6M
BP icon
13
BP
BP
$108B
$12.5M 1.46%
+367,449
New +$12.8M
FWONA icon
14
Liberty Media Series A
FWONA
$22.8B
$12.5M 1.45%
+553,834
New +$11.7M
MRK icon
15
Merck
MRK
$307B
$11.9M 1.38%
+267,664
New +$12M
LOW icon
16
Lowe's Companies
LOW
$115B
$11.1M 1.29%
+271,620
New +$10.9M
K
17
DELISTED
Kellanova
K
$10.9M 1.27%
+180,219
New +$10.9M
OXY icon
18
Occidental Petroleum
OXY
$54.9B
$10.5M 1.22%
+122,492
New +$10.3M
SYK icon
19
Stryker
SYK
$122B
$10.3M 1.19%
+158,640
New +$10.5M
PCG icon
20
PG&E
PCG
$38.4B
$9.81M 1.14%
+214,640
New +$9.91M
APC
21
DELISTED
Anadarko Petroleum
APC
$9.59M 1.12%
+111,653
New +$9.61M
GSK icon
22
GSK
GSK
$100B
$9.53M 1.11%
+152,536
New +$9.68M
CIT
23
DELISTED
CIT Group Inc.
CIT
$9.49M 1.1%
+203,545
New +$9M
WFC icon
24
Wells Fargo
WFC
$261B
$9.3M 1.08%
+225,307
New +$8.78M
DVN icon
25
Devon Energy
DVN
$50.5B
$8.87M 1.03%
+171,010
New +$9.53M

Similar funds

Platte River Capital's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Platte River Capital, which disclosed 198 positions worth $859M. Its ten largest holdings account for 21% of the portfolio.

Its largest position is Apple: 1,978,340 shares worth $28M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Technology and Energy.

  • Platte River Capital's largest Q2 2013 buy was Apple: 1,978,340 shares worth $28M.
  • Platte River Capital's ten largest holdings make up 21% of its $859M portfolio in Q2 2013.
  • Platte River Capital disclosed 198 positions in Q2 2013, its first 13F filing on record.

Based on Platte River Capital's 13F filing for Q2 2013, filed 19 Jul 2013.